Long‐term disease control of disseminated superficial actinic porokeratosis (DSAP) with simvastatin 2%/ cholesterol 2% cream
SC cream is a promising long-term, targeted treatment for DSAP, offering sustained efficacy, good tolerability, and improved QoL. The individual tapering from daily use to a proactive approach twice a week may be a key factor for disease control and may become an important component of skin tumor prevention in this specific patient population.
Authors
- Berenice M. Lang (ORCID: https://orcid.org/0000-0002-4679-3777)
- Gregor Ojak (ORCID: https://orcid.org/0009-0000-1675-186X)
- Joanna Wegner (ORCID: https://orcid.org/0000-0002-7710-9675)
- Petra Staubach (ORCID: https://orcid.org/0000-0002-2276-0284)
- Stephan Grabbe (ORCID: https://orcid.org/0000-0002-6863-8719)
- Caroline Mann (ORCID: https://orcid.org/0000-0001-7044-2216)
- Mandy Crummenauer
Institutions
- Goethe University Frankfurt (DE)
- University of Kaiserslautern (DE)
- University of Applied Sciences Mainz (DE)
- Photonik-Zentrum Kaiserslautern (DE)
- University Hospital Frankfurt (DE)
- Frankfurt University of Applied Sciences (DE)
- University of Applied Sciences Kaiserslautern (DE)
Publication Details
- Journal
- JDDG Journal der Deutschen Dermatologischen Gesellschaft
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1111/ddg.15950
- Primary Topic
- Genetic and rare skin diseases.
- Type
- article
- Field-Weighted Citation Impact
- 0.00